Stay updated on Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link. This replaces the study's detailed content and the previously listed MeSH terms on the page.SummaryDifference17%

- Check22 days agoChange DetectedThe page shows a revision update from v3.6.6 to v3.7.0, indicating a system/template version upgrade. This change does not modify the trial details or user-facing content.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.6.6 has been added, replacing Revision: v3.6.5. This indicates a small update to the page's revision metadata.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision indicator updated from v3.6.4 to v3.6.5, reflecting a minor maintenance update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision stamp was updated from v3.6.3 to v3.6.4, indicating a new version of the page content. This update is limited to metadata and does not modify the study information shown.SummaryDifference0.1%

Stay in the know with updates to Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.